Surging global incidence of cardiac arrhythmias, expanding diagnostic utilization of wearable electrocardiogram (ECG) monitors, and continuous pharmaceutical advancements in targeted ion-channel blocking therapies are driving rapid growth across the global Antiarrhythmic Drugs Market. Antiarrhythmic drug formulations—comprising Class I sodium channel blockers, Class II beta-blockers,...
